CZCheng-Cheng Zhang

Cheng-Cheng Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cheng-Cheng Zhang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Chunqing Ai

    SKL of Marine Food Processing & Safety Control, National Engineering Research Center of Seafood, Collaborative Innovation Center of Seafood Deep Processing, National & Local Joint Engineering Laboratory for Marine Bioactive Polysaccharide Development and Application, Liaoning Key Laboratory of Food Nutrition and Health, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, China

    1 shared publication
  • Jiadila Bahetiyaer

    State Key Laboratory of Marine Food Processing & Safety Control, Qingdao 266400, China

    1 shared publication
  • Jian Zhang

    College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China

    1 shared publication
  • Jie Cui

    College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China

    1 shared publication
  • Jin-Song Shi

    Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Life Sciences and Health Engineering, Jiangnan University, Wuxi 214122, China

    1 shared publication
  • Jinchi Jiang

    College of Food Science and Light Industry, Nanjing Tech University, Nanjing 211816, China

    1 shared publication

Latest Publications

  • Open Access

    Cereal Vinegar Sediment Modulates Gut Microbiota and Microbiota-Associated Metabolic Profiles in Mice with Short-Term High-Fat Diet Exposure

    by Wen-Hui Duan, Yi-Lin Ren, Qi-Jie Guan, Jin-Song Shi, Zheng-Hong Xu, Yu-Zheng Xue, Cheng-Cheng Zhang, Yi Guo, Yan Geng

    Background: Cereal vinegar sediment (CVS), a byproduct formed during traditional grain vinegar storage, possesses lipid-lowering, glucose-lowering, and antioxidant properties. However, its effects on gut microbial and metabolic responses to short-term high-fat diet (HFD) exposure remain unclear. This study aimed to characterize the compositional profiles of Dade CVS (DD-CVS) and Hengshun CVS (HS-CVS) and investigate their effects on host metabolism and gut microbiota in mice with short-term HFD exposure. Methodology: The physicochemical properties of CVSs were evaluated, and their chemical compositions were characterized via untargeted metabolomics. Mice were fed a short-term HFD and administered DD-CVS or HS-CVS. Fecal microbial communities were characterized by 16S rRNA gene sequencing, whereas cecal contents and serum were analyzed using untargeted metabolomics. Results: Both CVSs were rich in amino acids, their derivatives, and polyphenolic compounds. CVS treatments attenuated body-weight gain and reshaped the gut microbiota composition of mice, including changes in the relative abundance of Allobaculum, Akkermansia, and Lachnospiraceae_Clostridium. Differentially, DD-CVS enriched Blautia and Ruminococcus, whereas HS-CVS enriched Bacillus. The results of the gut microbial metabolic profiles showed that DD-CVS treatment regulated amino acid metabolism, while HS-CVS treatment influenced bile acid and arachidonic acid metabolism. Furthermore, serum metabolomics revealed that CVSs modulated systemic metabolic profiles and enriched CVS-associated compounds, such as α-linolenic acid. The candidate microbiota-sensitive metabolites, including lithocholic acid and 9(S)-HPODE, showed significant correlations with specific microbial taxa. Conclusions: DD-CVS and HS-CVS induced distinct gut microbial and metabolic responses during short-term HFD exposure, supporting further evaluation of CVS as a potential functional food.

  • Open Access

    Evaluating the Efficacy of Probiotics on Inflammatory Cytokines in Alcoholic Liver Disease: A Focus on IL-6 and IL-10

    by Jiadila Bahetiyaer, Jie Cui, Wenhui Li, Jian Zhang, Ye Sun, Chunqing Ai, Shuying Liu, Shuaiming Jiang, Chengcheng Zhang, Jinchi Jiang

    Background: While probiotics may offer therapeutic benefits for alcoholic liver disease (ALD), their impact on inflammatory markers in ALD patients is still uncertain. Objective: This study aims to investigate the effects of probiotic supplementation on inflammatory biomarkers in patients with alcoholic liver disease, particularly examining its role in modulating interleukin-6 (IL-6) levels. Methods: A comprehensive search was performed across PubMed, Embase, and Web of Science to identify randomized controlled trials investigating probiotic interventions in patients with alcoholic liver disease. Seven independent comparisons were chosen for meta-analysis to evaluate probiotics’ effects on inflammatory markers, with subgroup analyses examining the impact of region, formulation type, and gender. Results: The findings demonstrated that probiotics led to a significant reduction in IL-6 levels (SMD = −0.68, 95% CI [−1.15; −0.20], p = 0.005). No statistically significant effect of probiotics on interleukin-1β (IL-1β) (SMD = −0.35, 95% CI [−0.87, 0.17], p = 0.18) or tumor necrosis factor alpha (TNF-α) levels (SMD = −0.73, 95% CI [−1.68, 0.21], p = 0.13) was observed. Notably, probiotics were associated with a significant increase in interleukin-10 (IL-10) levels (SMD = 0.93,95% CI [−0.02; 1.87], p = 0.05). Subgroup analyses further revealed that the efficacy of probiotics in reducing IL-6 levels was more pronounced in studies characterized by higher proportions of Asian participants, solid dosage forms, and male subjects. Conclusions: Probiotics have notably reduced IL-6 levels by altering the gut microbiota and increased IL-10 levels, with limited impact on IL-1β and TNF-α. These results suggest probiotics could be used to treat ALD and emphasize the need for personalized probiotic approaches for different populations.